{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T19:49:45Z","timestamp":1723751385784},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,26]],"date-time":"2015-04-26T00:00:00Z","timestamp":1430006400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12889-015-1754-x","type":"journal-article","created":{"date-parts":[[2015,4,25]],"date-time":"2015-04-25T02:30:57Z","timestamp":1429929057000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The feasibility of epidemiological research on prostate cancer in African men in Ibadan, Nigeria"],"prefix":"10.1186","volume":"15","author":[{"given":"Ilir","family":"Agalliu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akin O","family":"Adebiyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W","family":"Lounsbury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oluwafemi","family":"Popoola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kola","family":"Jinadu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olukemi","family":"Amodu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suvam","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adebola","family":"Adedimeji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chioma","family":"Asuzu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Asuzu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olufemi J","family":"Ogunbiyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Rohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olayiwola B","family":"Shittu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,26]]},"reference":[{"key":"1754_CR1","volume-title":"Cancer Facts & Figures 2014","author":"American Cancer Society (ACS)","year":"2014","unstructured":"American Cancer Society (ACS). Cancer Facts & Figures 2014. Atlanta, GA: ACS; 2014."},{"key":"1754_CR2","volume-title":"SEER Cancer Statistics Review, 1975\u20132011","author":"N Howlader","year":"2014","unstructured":"Howlader N, Noone A, Krapcho M, Garshell J, Miller D, Altekruse S, et al. SEER Cancer Statistics Review, 1975\u20132011. Bethesda, MD: National Cancer Institute; 2014. http:\/\/seer.cancer.gov\/csr\/1975_2011\/ , based on November 2013 SEER data submission, posted to the SEER web site, April 2014."},{"issue":"1","key":"1754_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/caac.21254","volume":"65","author":"RL Siegel","year":"2015","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5\u201329.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"1754_CR4","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1056\/NEJM200007133430201","volume":"343","author":"P Lichtenstein","year":"2000","unstructured":"Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, et al. Environmental and heritable factors in the causation of cancer\u2013analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343(2):78\u201385.","journal-title":"N Engl J Med"},{"key":"1754_CR5","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.2741\/1891","volume":"11","author":"AW Hsing","year":"2006","unstructured":"Hsing AW, Chokkalingam AP. Prostate cancer epidemiology. Front Biosci. 2006;11:1388\u2013413.","journal-title":"Front Biosci"},{"issue":"2","key":"1754_CR6","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1046\/j.1464-410X.2002.2822.x","volume":"90","author":"M Quinn","year":"2002","unstructured":"Quinn M, Babb P. Patterns and Trends in Prostate Cancer Incidence, Survival, Prevalence and Mortality. Part I: International Comparisons. BJU Int. 2002;90(2):162\u201373.","journal-title":"BJU Int"},{"issue":"Suppl 1","key":"1754_CR7","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/1750-9378-4-S1-S2","volume":"4","author":"FT Odedina","year":"2009","unstructured":"Odedina FT, Akinremi TO, Chinegwundoh F, Roberts R, Yu D, Reams RR, et al. Prostate cancer disparities in Black men of African descent: a comparative literature review of prostate cancer burden among Black men in the United States, Caribbean, United Kingdom, and West Africa. Infect Agent Cancer. 2009;4 Suppl 1:S2.","journal-title":"Infect Agent Cancer"},{"issue":"2","key":"1754_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69\u201390.","journal-title":"CA Cancer J Clin"},{"key":"1754_CR9","doi-asserted-by":"publisher","first-page":"560857","DOI":"10.1155\/2013\/560857","volume":"2013","author":"TR Rebbeck","year":"2013","unstructured":"Rebbeck TR, Devesa SS, Chang BL, Bunker CH, Cheng I, Cooney K, et al. Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descent. Prostate Cancer. 2013;2013:560857.","journal-title":"Prostate Cancer"},{"issue":"5","key":"1754_CR10","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/ijc.11466","volume":"107","author":"DW Bruner","year":"2003","unstructured":"Bruner DW, Moore D, Parlanti A, Dorgan J, Engstrom P. Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis. Int J Cancer. 2003;107(5):797\u2013803.","journal-title":"Int J Cancer"},{"issue":"8","key":"1754_CR11","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1002\/cncr.11262","volume":"97","author":"MP Zeegers","year":"2003","unstructured":"Zeegers MP, Jellema A, Ostrer H. Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis. Cancer. 2003;97(8):1894\u2013903.","journal-title":"Cancer"},{"key":"1754_CR12","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1196\/annals.1386.040","volume":"1089","author":"MC Bosland","year":"2006","unstructured":"Bosland MC. Sex Steroids and Prostate Carcinogenesis: Integrated, Multifactorial Working Hypothesis. Ann N Y Acad Sci. 2006;1089:168\u201376.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"1754_CR13","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1093\/oxfordjournals.epirev.a000798","volume":"23","author":"LN Kolonel","year":"2001","unstructured":"Kolonel LN. Fat, Meat, and Prostate Cancer. Epidemiol Rev. 2001;23(1):72\u201381.","journal-title":"Epidemiol Rev"},{"issue":"1","key":"1754_CR14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1093\/oxfordjournals.epirev.a000775","volume":"23","author":"LK Dennis","year":"2001","unstructured":"Dennis LK, Hayes RB. Alcohol and Prostate Cancer. Epidemiol Rev. 2001;23(1):110\u20134.","journal-title":"Epidemiol Rev"},{"issue":"8","key":"1754_CR15","first-page":"719","volume":"11","author":"AR Kristal","year":"2002","unstructured":"Kristal AR, Cohen JH, Qu P, Stanford JL. Associations of Energy, Fat, Calcium, and Vitamin D With Prostate Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2002;11(8):719\u201325.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1754_CR16","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1097\/01.ju.0000107838.33623.19","volume":"171","author":"N Fleshner","year":"2004","unstructured":"Fleshner N, Bagnell PS, Klotz L, Venkateswaran V. Dietary fat and prostate cancer. J Urol. 2004;171:S19\u201324.","journal-title":"J Urol"},{"issue":"1","key":"1754_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/oxfordjournals.epirev.a000800","volume":"23","author":"JM Chan","year":"2001","unstructured":"Chan JM, Giovannucci EL. Dairy Products, Calcium, and Vitamin D and Risk of Prostate Cancer. Epidemiol Rev. 2001;23(1):87\u201392.","journal-title":"Epidemiol Rev"},{"issue":"32","key":"1754_CR18","doi-asserted-by":"publisher","first-page":"8152","DOI":"10.1200\/JCO.2005.03.1492","volume":"23","author":"JM Chan","year":"2005","unstructured":"Chan JM, Gann PH, Giovannucci EL. Role of diet in prostate cancer development and progression. J Clin Oncol. 2005;23(32):8152\u201360.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1754_CR19","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.canep.2010.11.002","volume":"35","author":"I Agalliu","year":"2011","unstructured":"Agalliu I, Kirsh VA, Kreiger N, Soskolne CL, Rohan TE. Oxidative balance score and risk of prostate cancer: Results from a case-cohort study. Cancer Epidemiol. 2011;35(4):353\u201361. doi: 10.1016\/j.canep.2010.11.002.","journal-title":"Cancer Epidemiol"},{"key":"1754_CR20","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s10552-006-0049-z","volume":"17","author":"RJ MacInnis","year":"2006","unstructured":"MacInnis RJ, English DR. Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control. 2006;17:989\u20131003.","journal-title":"Cancer Causes Control"},{"issue":"1","key":"1754_CR21","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/oxfordjournals.epirev.a000776","volume":"23","author":"K Hickey","year":"2001","unstructured":"Hickey K, Do KA, Green A. Smoking and prostate cancer. Epidemiol Rev. 2001;23(1):115\u201325.","journal-title":"Epidemiol Rev"},{"issue":"4","key":"1754_CR22","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.urology.2006.12.020","volume":"69","author":"S Rohrmann","year":"2007","unstructured":"Rohrmann S, Genkinger JM, Burke A, Helzlsouer KJ, Comstock GW, Alberg AJ, et al. Smoking and Risk of Fatal Prostate Cancer in a Prospective U.S. Study. Urology. 2007;69(4):721\u20135.","journal-title":"Urology"},{"issue":"4","key":"1754_CR23","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1177\/1534735402238186","volume":"1","author":"RW Pak","year":"2002","unstructured":"Pak RW, Lanteri VJ, Scheuch JR, Sawczuk IS. Review of vitamin E and selenium in the prevention of prostate cancer: implications of the selenium and vitamin E chemoprevention trial. Integr Cancer Ther. 2002;1(4):338\u201344.","journal-title":"Integr Cancer Ther"},{"key":"1754_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1207\/S15327914NC421_1","volume":"42","author":"AR Kristal","year":"2002","unstructured":"Kristal AR, Lampe JW. Brassica vegetables and prostate cancer risk: a review of the epidemiological evidence. Nutr Cancer. 2002;42:1\u20139.","journal-title":"Nutr Cancer"},{"key":"1754_CR25","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1158\/1055-9965.340.13.3","volume":"13","author":"M Etminan","year":"2004","unstructured":"Etminan M, Takkouche B, Caamano-Isorna F. The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies. Cancer Epidemiol Biomarkers Prev. 2004;13:340\u20135.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"1754_CR26","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s10552-005-0334-2","volume":"16","author":"M Etminan","year":"2005","unstructured":"Etminan M, FitzGerald JM, Gleave M, Chambers K. Intake of selenium in the prevention of prostate cancer: a systematic review and meta-analysis. Cancer Causes Control. 2005;16(9):1125\u201331.","journal-title":"Cancer Causes Control"},{"issue":"4","key":"1754_CR27","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/jnci\/djj050","volume":"98","author":"VA Kirsh","year":"2006","unstructured":"Kirsh VA, Hayes RB, Mayne ST, Chatterjee N, Subar AF, Dixon LB, et al. Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk. J Natl Cancer Inst. 2006;98(4):245\u201354.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"1754_CR28","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1158\/1055-9965.EPI-06-0973","volume":"16","author":"D Tang","year":"2007","unstructured":"Tang D, Liu JJ, Rundle A, Neslund-Dudas C, Savera AT, Bock CH, et al. Grilled Meat Consumption and Phip-Dna Adducts in Prostate Carcinogenesis. Cancer Epidemiol Biomark Prev. 2007;16(4):803\u20138.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1754_CR29","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/epirev\/mxm006","volume":"29","author":"SJ Freedland","year":"2007","unstructured":"Freedland SJ, Platz EA. Obesity and prostate cancer: making sense out of apparently conflicting data. Epidemiol Rev. 2007;29:88\u201397.","journal-title":"Epidemiol Rev"},{"issue":"3","key":"1754_CR30","doi-asserted-by":"crossref","first-page":"s843","DOI":"10.1093\/ajcn\/86.3.843S","volume":"86","author":"AW Hsing","year":"2007","unstructured":"Hsing AW, Sakoda LC, Chua Jr S. Obesity, metabolic syndrome, and prostate cancer. Am J Clin Nutr. 2007;86(3):s843\u201357.","journal-title":"Am J Clin Nutr"},{"issue":"8","key":"1754_CR31","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/carcin\/bgr066","volume":"32","author":"TA Wallace","year":"2011","unstructured":"Wallace TA, Martin DN, Ambs S. Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scale. Carcinogenesis. 2011;32(8):1107\u201321.","journal-title":"Carcinogenesis"},{"issue":"3","key":"1754_CR32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/CCO.0b013e32835eb5d1","volume":"25","author":"DN Martin","year":"2013","unstructured":"Martin DN, Starks AM, Ambs S. Biological determinants of health disparities in prostate cancer. Curr Opin Oncol. 2013;25(3):235\u201341.","journal-title":"Curr Opin Oncol"},{"issue":"6","key":"1754_CR33","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1210\/me.2013-1039","volume":"27","author":"IJ Powell","year":"2013","unstructured":"Powell IJ, Bollig-Fischer A. Minireview: the molecular and genomic basis for prostate cancer health disparities. Mol Endocrinol. 2013;27(6):879\u201391.","journal-title":"Mol Endocrinol"},{"key":"1754_CR34","volume-title":"World Cancer Report 2014","author":"International Agency for Research on Cancer (IARC)","year":"2014","unstructured":"International Agency for Research on Cancer (IARC). World Cancer Report 2014. 1st ed. Lyon, France: International Agency for Research on Cancer (IARC); 2014.","edition":"1"},{"key":"1754_CR35","volume-title":"GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012","author":"International Agency for Research on Cancer (IARC)","year":"2012","unstructured":"International Agency for Research on Cancer (IARC). GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. Geneva: World Health Organization; 2012."},{"issue":"3","key":"1754_CR36","first-page":"159","volume":"91","author":"JO Ogunbiyi","year":"1999","unstructured":"Ogunbiyi JO, Shittu OB. Increased incidence of prostate cancer in Nigerians. J Natl Med Assoc. 1999;91(3):159\u201364.","journal-title":"J Natl Med Assoc"},{"issue":"7","key":"1754_CR37","first-page":"619","volume":"94","author":"PD Ekwere","year":"2002","unstructured":"Ekwere PD, Egbe SN. The changing pattern of prostate cancer in Nigerians: current status in the southeastern states. J Natl Med Assoc. 2002;94(7):619\u201327.","journal-title":"J Natl Med Assoc"},{"issue":"5","key":"1754_CR38","doi-asserted-by":"publisher","first-page":"e271","DOI":"10.1016\/j.canep.2012.04.007","volume":"36","author":"E Jedy-Agba","year":"2012","unstructured":"Jedy-Agba E, Curado MP, Ogunbiyi O, Oga E, Fabowale T, Igbinoba F, et al. Cancer incidence in Nigeria: a report from population-based cancer registries. Cancer Epidemiol. 2012;36(5):e271\u20138.","journal-title":"Cancer Epidemiol"},{"issue":"4","key":"1754_CR39","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/S0022-5347(01)64966-8","volume":"157","author":"DN Osegbe","year":"1997","unstructured":"Osegbe DN. Prostate cancer in Nigerians: facts and nonfacts. J Urol. 1997;157(4):1340\u20133.","journal-title":"J Urol"},{"issue":"6","key":"1754_CR40","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1046\/j.1442-2042.2003.00633.x","volume":"10","author":"F Ukoli","year":"2003","unstructured":"Ukoli F, Osime U, Akereyeni F, Okunzuwa O, Kittles R, Adams-Campbell L. Prevalence of elevated serum prostate-specific antigen in rural Nigeria. Int J Urol. 2003;10(6):315\u201322.","journal-title":"Int J Urol"},{"key":"1754_CR41","doi-asserted-by":"publisher","first-page":"129","DOI":"10.11604\/pamj.2013.15.129.2489","volume":"15","author":"SO Ikuerowo","year":"2013","unstructured":"Ikuerowo SO, Omisanjo OA, Bioku MJ, Ajala MO, Mordi VP, Esho JO. Prevalence and characteristics of prostate cancer among participants of a community-based screening in Nigeria using serum prostate specific antigen and digital rectal examination. Pan African Med J. 2013;15:129.","journal-title":"Pan African Med J"},{"issue":"2","key":"1754_CR42","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4103\/1117-1936.170330","volume":"18","author":"CC Anunobi","year":"2011","unstructured":"Anunobi CC, Akinde OR, Elesha SO, Daramola AO, Tijani KH, Ojewola RW. Prostate diseases in Lagos, Nigeria: a histologic study with tPSA correlation. Niger Postgrad Med J. 2011;18(2):98\u2013104.","journal-title":"Niger Postgrad Med J"},{"key":"1754_CR43","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/BF02994508","volume":"14","author":"CA Okolo","year":"2008","unstructured":"Okolo CA, Akinosun OM, Shittu OB, Olapade-Olaopa EO, Okeke LI, Akang EEU, et al. Correlation of serum PSA and Gleason Score in Nigerian men with prostate cancer. Afr J Urol. 2008;14:15\u201322.","journal-title":"Afr J Urol"},{"key":"1754_CR44","volume-title":"Statistical Methods in Cancer Research, Volume 1-The Analysis of Case\u2013control Studies","author":"NE Breslow","year":"1980","unstructured":"Breslow NE, Day NE. Statistical Methods in Cancer Research, Volume 1-The Analysis of Case\u2013control Studies. Lyon: International Agency for Research on Cancer; 1980."},{"issue":"2","key":"1754_CR45","doi-asserted-by":"publisher","first-page":"120","DOI":"10.7326\/0003-4819-157-2-201207170-00459","volume":"157","author":"VA Moyer","year":"2012","unstructured":"Moyer VA, Force USPST. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157(2):120\u201334.","journal-title":"Ann Intern Med"},{"issue":"13","key":"1754_CR46","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1056\/NEJMoa0810696","volume":"360","author":"GL Andriole","year":"2009","unstructured":"Andriole GL, Crawford ED, Grubb 3rd RL, Buys SS, Chia D, Church TR, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009;360(13):1310\u20139.","journal-title":"N Engl J Med"},{"issue":"2","key":"1754_CR47","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/jnci\/djr500","volume":"104","author":"GL Andriole","year":"2012","unstructured":"Andriole GL, Crawford ED, Grubb 3rd RL, Buys SS, Chia D, Church TR, et al. Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13\u00a0years of follow-up. J Natl Cancer Inst. 2012;104(2):125\u201332.","journal-title":"J Natl Cancer Inst"},{"issue":"13","key":"1754_CR48","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","volume":"360","author":"FH Schroder","year":"2009","unstructured":"Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360(13):1320\u20138.","journal-title":"N Engl J Med"},{"issue":"9959","key":"1754_CR49","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1016\/S0140-6736(14)60525-0","volume":"384","author":"FH Schroder","year":"2014","unstructured":"Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Zappa M, Nelen V, et al. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13\u00a0years of follow-up. Lancet. 2014;384(9959):2027\u201335.","journal-title":"Lancet"},{"issue":"10","key":"1754_CR50","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1001\/jama.2014.9680","volume":"312","author":"IM Thompson Jr","year":"2014","unstructured":"Thompson Jr IM, Leach RJ, Ankerst DP. Focusing PSA testing on detection of high-risk prostate cancers by incorporating patient preferences into decision making. JAMA. 2014;312(10):995\u20136.","journal-title":"JAMA"},{"issue":"3","key":"1754_CR51","first-page":"145","volume":"19","author":"AA Ajape","year":"2009","unstructured":"Ajape AA, Babata A, Abiola OO. Knowledge of prostate cancer screening among native African urban population in Nigeria. Nig Q J Hosp Med. 2009;19(3):145\u20137.","journal-title":"Nig Q J Hosp Med"},{"issue":"3","key":"1754_CR52","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.juro.2014.04.017","volume":"192","author":"AW Hsing","year":"2014","unstructured":"Hsing AW, Yeboah E, Biritwum R, Tettey Y, De Marzo AM, Adjei A, et al. High prevalence of screen detected prostate cancer in West Africans: implications for racial disparity of prostate cancer. J Urol. 2014;192(3):730\u20135. doi: 10.1016\/j.juro.2014.04.017 .","journal-title":"J Urol"},{"issue":"9","key":"1754_CR53","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1093\/carcin\/bgr119","volume":"32","author":"E Taioli","year":"2011","unstructured":"Taioli E, Flores-Obando RE, Agalliu I, Blanchet P, Bunker CH, Ferrell RE, et al. Multi-institutional prostate cancer study of genetic susceptibility in populations of African descent. Carcinogenesis. 2011;32(9):1361\u20135.","journal-title":"Carcinogenesis"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-015-1754-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-015-1754-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-015-1754-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-015-1754-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T19:57:24Z","timestamp":1691611044000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-015-1754-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,26]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1754"],"URL":"https:\/\/doi.org\/10.1186\/s12889-015-1754-x","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,26]]},"article-number":"425"}}